Whole Genome Sequencing Market to Reach New Heights by 2030

"With cutting-edge advances in next-generation sequencing and growing interest in personalized medicine, whole genome sequencing is set to transform disease diagnosis and treatment, driving strong market growth at a projected CAGR of 15.1% over the next five years."

BOSTON, Aug. 13, 2025 /PRNewswire/ -- According to the latest study from BCC Research, "Whole Genome Sequencing: Global Markets" is projected to grow from $3 billion in 2025 to $6.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2030.

This report provides insights into the current and future market potential of whole genome sequencing (WGS), with global and regional projections through 2030. It includes market estimates by product and service type, covering instruments, consumables, and services. The workflow is segmented into pre-sequencing, sequencing, and data analysis. End users include research institutes, hospitals and clinics, pharmaceutical companies, and others. Applications span infectious diseases, cancer research, rare genetic diseases, and pharmacogenomics. The report also breaks down data by four regions: North America, Europe, Asia-Pacific, and the Rest of the World.

This report is particularly relevant today because whole genome sequencing (WGS) is emerging as a powerful tool for diagnosing, treating, and monitoring conditions like cancer, rare inherited disorders, and neurological diseases. Its ability to provide comprehensive genomic information helps reduce reliance on single-gene tests or invasive procedures. WGS is also increasingly used in drug development to identify better disease targets and select suitable patients for clinical studies through genomic profiling.

The factors driving the market's growth include:

Research on Cancer Genomics and Rare Inherited Diseases: Whole genome sequencing is vital for identifying genetic mutations linked to cancer and rare diseases. It enables faster, more accurate diagnoses and helps researchers develop targeted treatments by understanding disease mechanisms at the genetic level.

Falling Genome Sequencing Costs: Due to technological advances, the cost of sequencing a genome has dropped significantly, making it more accessible for clinical and research use. This affordability is expanding its adoption across the healthcare, biotech, and academic sectors.

Focus on Targeted Therapies and Personalized Medicine: WGS supports personalized medicine by revealing genetic profiles that guide treatment decisions. It helps tailor therapies to individual patients, improves drug response, and enables early disease detection and prevention strategies.

Request a sample copy of the global market for whole genome sequencing report.

Report Synopsis

Interesting facts:

• The growing focus on personal genomics and prenatal testing drives the market's growth across all regions.
• WGS-based diagnostics lead to more precise diagnosis and enable personalized treatment for each patient.

The report addresses the following questions:

1. What are the projected size and growth rate of the market?
   - The global EGS market was valued at $2.6 billion in 2024 and is expected to reach $6.1 billion by the end of 2030 at a CAGR of 15.1%.
   
   
2. Which factors are driving the growth of the market?
   - The increasing research on cancer genomics and rare inherited diseases and the growing focus on personalized medicine.
   
   
3. What are the key challenges and opportunities of the market?
   - Data analysis challenges and lack of infrastructure in emerging markets will challenge market growth during the forecast period.
   - The growing role of whole genome sequencing (WGS) in drug development and the increasing government initiatives to promote it create market opportunities.
   
   
4.  Which market segments are covered in the report?
   - The market is segmented based on product and service type, workflow, application, end user and region. Product and service types include consumables, instruments, and services. Consumables are further segmented into library preparation kits, reagents and accessories.
   -  Workflow sub-segments include pre-sequencing, sequencing, and data analysis. End users include research institutes, hospitals and clinics, and pharmaceutical companies. Applications include infectious diseases, cancer research, rare genetic diseases, and pharmacogenomics. The market is segmented by geographical region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe. Asia-Pacific includes China, Japan, India, Australia, South Korea, and the Rest of Asia-Pacific. The Rest of the World (RoW) includes South America, the Middle East and Africa. It includes global revenue ($ Million) for the base year of 2024 and estimated data for the forecast period 2025 through 2030.
   
   
5.  Which product type will be dominant through 2030?
   - Consumables segment will dominate the market through the forecast period.
   
   
6. Which region has the highest market share?
   - North America accounted for a 50.9% share of the market in 2024.

Related reports:

Global Microbiome Sequencing Market: The report analyzes the microbiome sequencing market, segmenting it by component, sequencing technology, laboratory type, application, and end user. It explores trends, market drivers, restraints, and opportunities, along with macroeconomic influences and regulatory developments. The study also highlights technological innovations, patent activity, ESG factors, and competitive dynamics, including profiles of leading companies. Regions covered include North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, providing a global perspective on market growth and challenges.

Global DNA Sequencing: Research, Applied and Clinical Markets: This report presents an in-depth analysis of the DNA sequencing market, focusing on its status and future potential. It explores market drivers, restraints, and opportunities, along with competitive dynamics and product offerings. The market is segmented by technology (NGS, TGS, pyrosequencing, and Sanger sequencing), product and service types, end users, applications, and disease categories. It also includes company profiles with financials, product portfolios, and recent developments. Geographically, the report covers North America, Europe, Asia-Pacific, and the Rest of the World, offering a global perspective on market trends and forecasts.

Purchase a copy of the report direct from BCC Research.

For further information on any of these reports or to make a purchase, contact [email protected].    

About BCC Research

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

Contact Us

Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA

Email: [email protected]

Phone: +1 781-489-7301

For media inquiries, email [email protected] or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo - https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

SOURCE BCC Research LLC